Return On Assets of BioXcel Therapeutics, Inc. from 30 Sep 2018 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
- Summary
-
BioXcel Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2018 to 31 Dec 2025.
- BioXcel Therapeutics, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -181%, a 79% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Return On Assets for 2025 was -181%, a 79% decline from 2024.
- BioXcel Therapeutics, Inc. annual Return On Assets for 2024 was -101%, a 30% increase from 2023.
- BioXcel Therapeutics, Inc. annual Return On Assets for 2023 was -145%, a 99% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)
BioXcel Therapeutics, Inc. Quarterly Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -181% | -80% | -79% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -185% | -80% | -76% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -134% | -0.46% | -0.34% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -84% | +71% | +46% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -101% | +43% | +30% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -105% | +30% | +22% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -134% | -29% | -27% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -154% | -69% | -81% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -145% | -72% | -99% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -135% | -77% | -132% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -105% | -54% | -107% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -85% | -40% | -89% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -73% | -29% | -67% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -58% | -16% | -37% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -51% | -8.4% | -20% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -45% | +6.2% | +12% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -44% | +9.9% | +19% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -42% | +22% | +34% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -42% | +48% | +53% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -51% | +30% | +37% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -53% | +32% | +37% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -64% | +14% | +18% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -91% | -24% | -36% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -81% | -33% | -68% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -85% | -46% | -120% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -79% | -41% | -109% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | -67% | 01 Apr 2019 | 30 Jun 2019 | ||
| Q1 2019 | -49% | 01 Jan 2019 | 31 Mar 2019 | ||
| Q4 2018 | -39% | 01 Oct 2018 | 31 Dec 2018 | ||
| Q3 2018 | -38% | 01 Jul 2018 | 30 Sep 2018 |
BioXcel Therapeutics, Inc. Annual Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -181% | -80% | -79% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -101% | +43% | +30% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -145% | -72% | -99% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -73% | -29% | -67% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -44% | +9.9% | +19% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -53% | +32% | +37% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -85% | -46% | -120% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -39% | 01 Jan 2018 | 31 Dec 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.